Solitomab Biosimilar – Anti-CD3E, EpCAM mAb – Research Grade

Reference:
3 reviews Write a review
Size

,

Brand

Product type

Clonality

Expression system

Applications

Product nameSolitomab Biosimilar - Anti-CD3E, EpCAM mAb - Research Grade
SourceCAS 1005198-65-1
SpeciesMus musculus
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsSolitomab,MT110,CD3E, EpCAM,anti-CD3E, EpCAM
ReferencePX-TA1282
NoteFor research use only. Not suitable for clinical or therapeutic use.
Isotype(scFv-kappa-heavy)-(scFv-heavy-kappa)
ClonalityMonoclonal Antibody

General information on Anti-CD3E/EpCAM[Homo sapiens] (Solitomab) Monoclonal Antibody

Solitomab has been investigated for the treatment of Lung Cancer, Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer.

SDS-PAGE for Solitomab Biosimilar - Anti-CD3E, EpCAM mAb

Solitomab Biosimilar - Anti-CD3E, EpCAM mAb, on SDS-PAGE under reducing

Reviews

  • Vele

    Great product!

  • Vele

    Great product!

  • Vele

    Great product!

REVIEW YOUR PRODUCT

Add a review

Your email address will not be published. Required fields are marked *

Related products

CD3E Recombinant Protein
Antigen CD3E Recombinant Protein PX-P4075 310€
Human T-cell surface glycoprotein CD3 epsilon chain (CD3E) recombinant protein
Antigen Human T-cell surface glycoprotein CD3 epsilon chain (CD3E) recombinant protein PX-P4014 210€
Human CD326 recombinant protein
Antigen Human CD326 recombinant protein PX-P5122 110€
Stable Istotope Labelled Solitomab Biosimilar – Anti-CD3E/EpCAM mAb – Research Grade
SIL Stable Istotope Labelled Solitomab Biosimilar – Anti-CD3E/EpCAM mAb – Research Grade PX-TA1282-SIL 1500€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.